We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$604M
1-Year Est. Return
96.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.32%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$210M
AUM Growth
+$31.7M
(+18%)
Cap. Flow
-$9.22M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
41.52%
Holding
75
New
29
Increased
9
Reduced
14
Closed
17
Avg Time Held Equity + Options
1.4
quarters
Top 10 Avg Time Held Equity + Options
1.7
quarters
Top 20 Avg Time Held Equity + Options
1.5
quarters
Avg Time Held Equity only
1.9
quarters
Top 10 Avg Time Held Equity only
2.2
quarters
Top 20 Avg Time Held Equity only
2.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$5.11M |
| 2 |
Avanos Medical
AVNS
|
+$3.8M |
| 3 |
Revvity
RVTY
|
+$3.35M |
| 4 |
ELGX
Endologix Inc
ELGX
|
+$2.9M |
| 5 |
NEVRO CORP.
NVRO
|
+$2.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$7.56M |
| 2 |
GSK
GSK
|
+$6.33M |
| 3 |
Cardinal Health
CAH
|
+$4.73M |
| 4 |
Puma Biotechnology
PBYI
|
+$4.48M |
| 5 |
Sanofi
SNY
|
+$4.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.95% |
| 2 | Miscellaneous | 37.36% |
| 3 | Financials | 3.75% |
| 4 | Industrials | 2.24% |
| 5 | Technology | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $17.4M | 8.27% |
59,128
+676
| +1% | +$191K |
2014 Q4
10 quarters
|
|
2
PUT
Johnson & Johnson
JNJ
$599B
| $9.26M | 4.4% |
70,000
+40,000
| +133% | +$5.1M |
2017 Q1
1 quarter
|
|
|
3
Sanofi
SNY
$93.7B
| $8.7M | 4.14% |
181,622
-88,800
| -33% | -$4.24M |
2017 Q1
1 quarter
|
|
4
PUT
Intuitive Surgical
ISRG
$149B
| $8.61M | 4.09% |
+82,800
| New | +$7.96M |
2017 Q2
0 quarters
|
|
|
AET
5
DELISTED
Aetna Inc
AET
| $7.89M | 3.75% |
52,000
+14,900
| +40% | +$2.11M |
2016 Q4
2 quarters
|
|
|
ACOR
6
PUT
DELISTED
Acorda Therapeutics
ACOR
| $7.49M | 3.56% |
3,167
-5,545
| -64% | -$11M |
2017 Q1
1 quarter
|
|
|
AGN
7
PUT
DELISTED
Allergan plc
AGN
| $7.29M | 3.47% |
+30,000
| New | +$7.05M |
2017 Q2
0 quarters
|
|
8
Philips
PHG
$24.3B
| $7.01M | 3.33% |
257,669
-72,118
| -22% | -$1.89M |
2016 Q1
5 quarters
|
|
|
9
Puma Biotechnology
PBYI
$522M
| $6.99M | 3.32% |
80,021
-80,043
| -50% | -$4.48M |
2017 Q1
1 quarter
|
|
|
LPNT
10
PUT
DELISTED
LifePoint Health, Inc.
LPNT
| $6.71M | 3.19% |
+100,000
| New | +$6.32M |
2017 Q2
0 quarters
|
|
11
Thermo Fisher Scientific
TMO
$245B
| $6.28M | 2.98% |
35,965
+5,965
| +20% | +$1M |
2017 Q1
1 quarter
|
|
|
12
HCA Healthcare
HCA
$99.8B
| $5.27M | 2.5% |
+60,420
| New | +$5.11M |
2017 Q2
0 quarters
|
|
|
SGEN
13
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.17M | 2.46% |
+100,000
| New | +$6.36M |
2017 Q2
0 quarters
|
|
14
PUT
AbbVie
ABBV
$485B
| $5.08M | 2.41% |
+70,000
| New | +$4.71M |
2017 Q2
0 quarters
|
|
|
15
GSK
GSK
$92.7B
| $4.88M | 2.32% |
90,490
-118,720
| -57% | -$6.33M |
2016 Q4
2 quarters
|
|
16
PUT
DELISTED
Sage Therapeutics
SAGE
| $4.78M | 2.27% |
60,000
-42,800
| -42% | -$3.09M |
2017 Q1
1 quarter
|
|
|
TRHC
17
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $4.71M | 2.24% |
312,630
-101,415
| -24% | -$1.37M |
2016 Q3
3 quarters
|
|
18
PUT
Insmed
INSM
$21.1B
| $4.58M | 2.17% |
266,600
+181,600
| +214% | +$3.1M |
2017 Q1
1 quarter
|
|
19
PUT
Agios Pharmaceuticals
AGIO
$1.8B
| $4.28M | 2.03% |
+83,100
| New | +$4.25M |
2017 Q2
0 quarters
|
|
20
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $4.24M | 2.01% |
108,523
| – | – |
2015 Q4
6 quarters
|
|
|
21
DELISTED
Avanos Medical
AVNS
| $3.95M | 1.88% |
+100,599
| New | +$3.8M |
2017 Q2
0 quarters
|
|
22
UnitedHealth
UNH
$339B
| $3.92M | 1.86% |
21,151
| – | – |
2016 Q3
3 quarters
|
|
23
Globus Medical
GMED
$10.2B
| $3.76M | 1.79% |
113,400
+53,400
| +89% | +$1.68M |
2017 Q1
1 quarter
|
|
24
Rigel Pharmaceuticals
RIGL
$881M
| $3.67M | 1.75% |
134,572
-54,246
| -29% | -$1.48M |
2016 Q1
5 quarters
|
|
|
25
Revvity
RVTY
$17.3B
| $3.67M | 1.75% |
+53,899
| New | +$3.35M |
2017 Q2
0 quarters
|
|
Similar funds
EFL
V
MAM
RCM
AMG
VV
VCP
EHI
Sio Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Sio Capital Management held 75 positions worth $210M, up 18% from $179M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Sio Capital Management withdrew a net $9.22M in Q2 2017, closing 17 positions and reducing 14 holdings. Its most notable exit was Biogen, an estimated $7.56M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 66% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Sio Capital Management opened a new position in HCA Healthcare worth $5.27M.
- Sio Capital Management's largest Q2 2017 buy was HCA Healthcare: 60,420 shares worth $5.27M.
- Sio Capital Management added most to Aetna Inc in Q2 2017, an estimated $2.11M increase.
- Sio Capital Management's biggest Q2 2017 reduction was GSK, cutting an estimated $6.33M.
- Sio Capital Management fully exited Biogen in Q2 2017, selling an estimated $7.56M.
- Sio Capital Management's ten largest holdings make up 42% of its $210M portfolio in Q2 2017.
- Sio Capital Management opened 29 new positions and closed 17 in Q2 2017.
- Sio Capital Management's portfolio value rose 18% quarter-over-quarter to $210M.
Based on Sio Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.